ClinicalTrials.Veeva

Menu

The AMPER Study: Evaluation of the Efficacy of Human Amniotic Membrane Grafting in Preventing Mesh Exposure in Vaginal Reconstructive Surgery Using Polypropylene Mesh.

H

Hospital General de Agudos J. M. Penna

Status

Not yet enrolling

Conditions

Pelvic Organ Prolapse Vaginal Surgery
Stress Urinary Incontinence in Women

Treatments

Procedure: Sacrospinous Hysteropexy with Mesh
Procedure: Transobturator Mid-urethral Sling (Out-In)
Procedure: Retropubic Mid-urethral Sling (Bottom-Up)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study evaluates the efficacy of adding a human amniotic membrane graft to polypropylene mesh surgery for pelvic prolapse and stress urinary incontinence. The goal is to assess improvements in tissue integration and the reduction of surgical complications

Enrollment

330 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pelvic organ prolapse (POP) stage II C or greater, defined as C ≥ +1, in women without prior hysterectomy and/or with a diagnosis of stress urinary incontinence seeking surgical treatment.
  • Ability to understand study information and provide written informed consent.
  • Availability for follow-up for a minimum of 12 months.

Exclusion criteria

  • Previous surgery with synthetic mesh (via vaginal or abdominal approach) for POP repair.
  • Known adverse reaction to synthetic meshes.
  • Unresolved or active chronic pelvic pain.
  • History of prior abdominal or pelvic radiation.
  • Contraindication to the planned surgical procedure.
  • Current pregnancy.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

330 participants in 2 patient groups

With amniotic membrane
Experimental group
Description:
Patients undergoing surgery for pelvic organ prolapse or stress urinary incontinence with polypropylene mesh in whom a dehydrated human amniotic membrane patch was placed over the mesh or sling prior to vaginal closure.
Treatment:
Procedure: Retropubic Mid-urethral Sling (Bottom-Up)
Procedure: Transobturator Mid-urethral Sling (Out-In)
Procedure: Sacrospinous Hysteropexy with Mesh
without amniotic membrane, surgery alone
Active Comparator group
Description:
Patients undergoing surgery for pelvic organ prolapse or stress urinary incontinence with polypropylene mesh without human amniotic membrane patch
Treatment:
Procedure: Retropubic Mid-urethral Sling (Bottom-Up)
Procedure: Transobturator Mid-urethral Sling (Out-In)
Procedure: Sacrospinous Hysteropexy with Mesh

Trial contacts and locations

1

Loading...

Central trial contact

Ileana Sanger, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems